Venter's fellow travelers

J. Craig Venter's vow to build the world's largest human sequencing operation has drawn at least two previous investors to his latest genomics play.

Venter launched Human Longevity Inc. last week with a $70 million series A round to build a database of genotype data along with microbiome and metabolomics data for aging-related diseases, as well as to develop diagnostics and cell therapies...